Saladax Expands Global Access to Drug Monitoring Tests
BETHLEHEM, PA, April 7, 2026 Saladax Biomedical, Inc. has announced a strategic distribution agreement with Thermo Fisher Scientific to...
Alzheimer’s Disease Autoimmune Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy GMP Immuno-Oncology immunology Immunotherapy Medical Devices MedTech medtech innovation Monoclonal Antibody NSCLC Oncology oncology innovation Orphan Drug orphan drug designation patient access Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory approval regulatory compliance targeted therapy
BETHLEHEM, PA, April 7, 2026 Saladax Biomedical, Inc. has announced a strategic distribution agreement with Thermo Fisher Scientific to...
WALTHAM, Mass., USA — April 2, 2026 Thermo Fisher Scientific Inc. has announced the global launch of the Gibco™...
March 05, 2026 — South San Francisco, California, USA Global life sciences leader Thermo Fisher Scientific has announced the...
WALTHAM, Mass., Nov. 24, 2025 — Thermo Fisher Scientific announced the successful pricing of its euro-denominated senior notes offering,...
